vaccine

Lack of Trust in Doctors Undermines Covid-19 Vaccination Strategy

Recent data from the Financial Trust Index (FTI) reveals that Americans are not as willing to be vaccinated as the government expects....

How Pfizer’s Vaccine Announcement Demonstrates the Political Power of Firms

By timing the disclosure of the results of its vaccine trial, Pfizer could have influenced the 2020 presidential election. This is worrisome...

The Covid-19 Vaccine is Nearly Here. The Question is: Will People Take It?

In addition to the challenges involved in manufacturing and distributing the new Covid vaccine from Pfizer, the reluctance of many Americans to...

Regulators Should Keep a Close Eye on the Little Guys in the Race for a Covid-19 Vaccine

As the race to find a Covid-19 vaccine or treatment rages on, many have raised concerns over trustworthiness of clinical research and...

A New Capitalisn’t Episode: a Coronavirus Reading List

In this episode, Kate and Luigi give an economist's view of the coronavirus outbreak: How should we think about the economic trade-offs of interventionist...

LATEST NEWS

New Research Shows The Breakup of IG Farben Increased Innovation

IG Farben used to be the world’s largest chemical company and a major innovator—until it was broken up in one of the...

Why Streaming Doesn’t Pay

An excerpt from a new book, Chokepoint Capitalism: How Big Tech and Big Content Captured Creative Labor Markets and How We'll Win...

Democratize Work

An excerpt from a new book, Democratize Work: The Case for Reorganizing the Economy, advocates democratizing firms and decommodifying work.

Antitrust Enforcement, Inflation and Corporate Greed: What do we know?

At a recent Centre for Economic Policy Research (CEPR) event, panelists, including the Stigler Center's own Luigi Zingales, reflected on the roles...

Data is Abundant But is it Accessible to Researchers?

Despite the wide availability of data, ensuring independent access to data sources has never been more crucial. How can researchers engage in...